We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pembina Pipeline (PBA) to Restart Work on Two Delayed Projects
Read MoreHide Full Article
Pembina Pipeline Corporation (PBA - Free Report) plans to expend C$785 million ($616.27 million) as capital expenditure next year and said that it will recommence operations on two major projects. Further, it projects adjusted EBITDA of C$3.2-C$3.4 billion in 2021.
The company in its 2021 capital guidance mentioned that it will continue the next phase of its Peace Pipeline expansion and the Empress Co-generation facility in Calgary, Alberta. In March, the projects were postponed as the coronavirus crisis caused economic slowdowns that undermined the entire energy sector with low crude prices and decreased demand.
The Phase VII Peace pipeline expansion involves a new pipeline system and related facilities in the LaGlace-Valleyview-Fox Creek corridor in Alberta to address the increasing customer demand. Notably, the company reduced its capital cost estimate by C$175 million to C$775 million, thereby, curtailing the pipeline’s initial capacity from 240,000 to 160,000 barrels per day.
Beside this, the Empress Co-generation facility, which is expected to cost C$120 million, will use natural gas to produce up to 45 megawatts (“MW”) of electrical power and re-use the generated heat in its regular operations. The output is expected to supply more than 90% of the facility’s requirements and utilize the extracted fuel from the plant’s processing function. Notably, the project is likely to reduce carbon dioxide emissions by 88,000 tonnes per year from the propane-to-plastics facility.
On its part, the projects offer more growth opportunities for Pembina Pipeline’s market presence across the entire value chain since prices have recovered from the all-time low hit earlier this year amid the pandemic, urging producers to restart their shut-in activities and increase capital expenditure.
Further, Pembina Pipeline announced the discontinuation of its C$4.9-billion joint venture project — Canada Kuwait Petrochemical Ltd Partnership — with Petrochemical Industries Company K.S.C on the combined propane dehydration plant and polypropylene upgrading facility. The action was mainly due to the significant risks, mostly related to project costs, arising from the pandemic. The company added that it will take a material impairment on its investment in the joint venture project in the Alberta province, where it owns a 50% stake, in the fourth quarter.
Company Profile & Price Performance
Headquartered in Calgary, Canada, Pembina Pipeline is an energy transportation and service provider. Its shares have underperformed the industry in the past three months. The company’s stock has gained 11.2% compared with the industry’s 12.7% growth.
Zacks Rank & Stocks to Consider
Pembina Pipeline currently carries a Zack Rank #3 (Hold).
Some better-ranked players in the energy space are Hess Midstream Partners LP (HESM - Free Report) , China Petroleum & Chemical Corporation , currently sporting a Zacks Rank #1 (Strong Buy), and Canadian Natural Resources Limited (CNQ - Free Report) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, the Zacks Consensus Estimate for Hess Midstream’s2020 earnings has been raised by 1462.5%, while that for China Petroleum’s 2020 earnings has been raised by 219.3%.
Canadian Natural Resources is expected to see earnings growth of 560.7% in 2021.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Pembina Pipeline (PBA) to Restart Work on Two Delayed Projects
Pembina Pipeline Corporation (PBA - Free Report) plans to expend C$785 million ($616.27 million) as capital expenditure next year and said that it will recommence operations on two major projects. Further, it projects adjusted EBITDA of C$3.2-C$3.4 billion in 2021.
The company in its 2021 capital guidance mentioned that it will continue the next phase of its Peace Pipeline expansion and the Empress Co-generation facility in Calgary, Alberta. In March, the projects were postponed as the coronavirus crisis caused economic slowdowns that undermined the entire energy sector with low crude prices and decreased demand.
The Phase VII Peace pipeline expansion involves a new pipeline system and related facilities in the LaGlace-Valleyview-Fox Creek corridor in Alberta to address the increasing customer demand. Notably, the company reduced its capital cost estimate by C$175 million to C$775 million, thereby, curtailing the pipeline’s initial capacity from 240,000 to 160,000 barrels per day.
Beside this, the Empress Co-generation facility, which is expected to cost C$120 million, will use natural gas to produce up to 45 megawatts (“MW”) of electrical power and re-use the generated heat in its regular operations. The output is expected to supply more than 90% of the facility’s requirements and utilize the extracted fuel from the plant’s processing function. Notably, the project is likely to reduce carbon dioxide emissions by 88,000 tonnes per year from the propane-to-plastics facility.
On its part, the projects offer more growth opportunities for Pembina Pipeline’s market presence across the entire value chain since prices have recovered from the all-time low hit earlier this year amid the pandemic, urging producers to restart their shut-in activities and increase capital expenditure.
Further, Pembina Pipeline announced the discontinuation of its C$4.9-billion joint venture project — Canada Kuwait Petrochemical Ltd Partnership — with Petrochemical Industries Company K.S.C on the combined propane dehydration plant and polypropylene upgrading facility. The action was mainly due to the significant risks, mostly related to project costs, arising from the pandemic. The company added that it will take a material impairment on its investment in the joint venture project in the Alberta province, where it owns a 50% stake, in the fourth quarter.
Company Profile & Price Performance
Headquartered in Calgary, Canada, Pembina Pipeline is an energy transportation and service provider. Its shares have underperformed the industry in the past three months. The company’s stock has gained 11.2% compared with the industry’s 12.7% growth.
Zacks Rank & Stocks to Consider
Pembina Pipeline currently carries a Zack Rank #3 (Hold).
Some better-ranked players in the energy space are Hess Midstream Partners LP (HESM - Free Report) , China Petroleum & Chemical Corporation , currently sporting a Zacks Rank #1 (Strong Buy), and Canadian Natural Resources Limited (CNQ - Free Report) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, the Zacks Consensus Estimate for Hess Midstream’s2020 earnings has been raised by 1462.5%, while that for China Petroleum’s 2020 earnings has been raised by 219.3%.
Canadian Natural Resources is expected to see earnings growth of 560.7% in 2021.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>